Pharmacological profiles of the putative dopamine autoreceptor agonists 3-PPP and TL-99.

No abstract is available for this paper.

• Publication year

  1981

• Venue

  European Journal of Pharmacology

• Publication date

  1981-11-19

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0014-2999(81)90004-2PMID 7318920
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats

  2004cited by this paper
• 3-PPP, a new centrally acting DA-receptor agonist with selectivity for autoreceptors.

  1981cited by this paper
• Cardiovascular effects of 2‐(NN‐dimethyl)amino‐6,7‐dihydroxy‐1,2,3,4 tetrahydronaphthalene in pithed rats: differential antagonism by yohimbine and prazosin

  1980cited by this paper
• Brain dopamine receptors.

  1980cited by this paper
• A new centrally acting DA-receptor agonist with selectivity for autoreceptors.

  1980cited by this paper
• Neurochemical and behavioral evidence for a selective presynaptic dopamine receptor agonist.

  1980cited by this paper
• An in vivo model for investigating alpha 1- and alpha 2-receptors in the CNS: studies with mianserin.

  1979cited by this paper
• Apomorphine hydrochloride-induced improvement in Huntington's chorea: stimulation of dopamine receptor.

  1978cited by this paper
• Do presynaptic auto-receptors control dopamine release?

  1978cited by this paper
• Schizophrenic symptoms improve with apomorphine.

  1978cited by this paper
• Dopamine “Autoreceptors”: Pharmacological characterization by microiontophoretic single cell recording studies

  1977cited by this paper
• Evidence for dopamine receptors mediating sedation in the mouse brain

  1976cited by this paper
• Comparison of the effects of neuroleptic drugs on pre- and postsynaptic dopaminergic mechanisms in the rat striatum.

  1976cited by this paper
• Properties of [3H]haloperidol and [3H]dopamine binding associated with dopamine receptors in calf brain membranes.

  1976cited by this paper
• Dopaminergic neurons: An in vivo system for measuring drug interactions with presynaptic receptors

  1976cited by this paper
• Dopamine receptors in human and calf brains, using [3H]apomorphine and an antipsychotic drug.

  1976cited by this paper
• Evidence for drug actions on both pre- and postsynaptic catecholamine receptors in the CNS.

  1975cited by this paper
• Self-inhibition by dopaminergic neurons

  1975cited by this paper
• Improved automated apparatus for recording rotation (circling behavior) in rats or mice.

  1975cited by this paper
• Antagonistic effects of apomorphine and haloperidol on rat striatal synaptosomal tyrosine hydroxylase

  1974cited by this paper
• Evidence for a receptor‐mediated feedback control of striatal tyrosine hydroxylase activity

  1972cited by this paper
• Drug-induced changes in the release of 3 H-monoamines from field stimulated rat brain slices.

  1971cited by this paper
• Drug-Induced Changes in the Release of 3H-Monoamines from Field Stimulated Rat Brain Slices

  1971cited by this paper
• Action of various centrally acting agents in mice with unilateral caudate brain lesions.

  1971cited by this paper
• Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour.

  1971cited by this paper
• The inhibition of catecholamine biosynthesis by apomorphine

  1970cited by this paper
• Statistical Principles in Experimental Design

  1963cited by this paper

• The syntheses and applications of β-benzylmercaptoethylamine derivatives

  2009cites this paper
• Effects of B-HT 920 and B-HT 933 on dopamine and noradrenaline autoreceptors in the rat brain.

  2009cites this paper
• (+)-UH 232 and (+)-UH 242: Novel stereoselective dopamine receptor antagonists with preferential action on autoreceptors

  2005cites this paper
• Dopamine-receptor agonists: Mechanisms underlying autoreceptor selectivity

  2005cites this paper
• Postsynaptic dopamine agonistic effects of 3-PPP enantiomers revealed by bilateral 6-hydroxy-dopamine lesions and by chronic reserpine treatment in rats

  2005cites this paper
• Dopamine receptor agonists: Intrinsic activity vs. state of receptor

  2005cites this paper
• Sub-chronic administration of (−)-3-PPP and central dopamine receptor sensitivity changes

  2005cites this paper
• Dopamine receptor agonistic and antagonistic effects of 3-PPP enantiomers

  2004cites this paper
• The effect of the enantiomers of 3-PPP on conditioned avoidance responding in the rat

  2004cites this paper
• Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP

  2004cites this paper
• Involvement of septal and striatal dopamine D-2 receptors in yawning behavior in rats

  2004cites this paper
• Pre-synaptic dopaminergic control mechanisms for CCK-8 like immunoreactivity in the rat medial frontal cortex.

  1992cites this paper
• Biochemical and pharmacological characterization of the putative dopamine autoreceptor agonist benzopyranopyridine, CGS 15873A

  1989cites this paper
• Dopamine autoreceptor agonists attenuate spontaneous motor activity but not spontaneous fighting in individually-housed mice.

  1989cites this paper
• 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist.

  1988cites this paper
• Presynaptic Receptors on Catecholamine Neurones

  1988cites this paper
• Dopamine autoreceptor agonists: resolution and pharmacological activity of 2,6-diaminotetrahydrobenzothiazole and an aminothiazole analogue of apomorphine.

  1987cites this paper
• Effects of apomorphine and (+/-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine, injected into the striatum, on the caudate spindle in the rat.

  1987cites this paper
• Synthesis and dopaminergic activity of trans-4-methyl-3-phenylpyrrolidines

  1987cites this paper
• [Anti-dopaminergic activity of pyrrolidinyl-benzamide derivatives].

  1987cites this paper
• Dopamine receptors mediating yawning: are they autoreceptors?

  1986cites this paper
• Effects of dopaminomimetics on the secretion of VIP-like immunoreactivity in conscious dogs.

  1986cites this paper
• The dopamine autoreceptor agonist B-HT 920 stimulates denervated postsynaptic brain dopamine receptors in rodent and primate models of Parkinson's disease: a novel approach to treatment.

  1986cites this paper
• Electrophysiological effects of the enantiomers of 3-PPP on neurons in the locus coeruleus of the rat.

  1986cites this paper
• Direct inhibition of tyrosine hydroxylase from PC-12 cells by catechol derivatives

  1986cites this paper
• Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.

  1985cites this paper
• Dopamine Autoreceptor Stimulation Increases Protein Carboxyl Methylation in Striatal Slices

  1985cites this paper
• Agonist and antagonist effects of 3-PPP enantiomers on functional dopamine autoreceptors and postsynaptic dopamine receptors in vitro.

  1985cites this paper
• Dopamine agonists: structure-activity relationships.

  1985cites this paper
• Pharmacological properties of presynaptic dopamine receptor agonists.

  1985cites this paper
• Dopamine receptors: Functions, subtypes and emerging concepts

  1985cites this paper
• An electrophysiological analysis of the actions of the 3-PPP enantiomers on the nigrostriatal dopamine system

  1985cites this paper
• Interaction of (+)- and (−)-3-PPP with the dopamine receptor in the anterior pituitary gland

  1984cites this paper
• Effects of apomorphine, TL-99 and 3-PPP on yawning in rats.

  1984cites this paper
• Pharmacologic profile of a novel potent direct-acting dopamine agonist, (+)-4-propyl-9-hydroxynaphthoxazine [(+)-PHNO].

  1984cites this paper
• Electrophysiological, biochemical and behavioral assessment of dopamine autoreceptor activation by a series of dopamine agonists.

  1984cites this paper
• Effects of S (+)-3-phenethyl-PP, a putative dopamine autoreceptors agonist with greater autoreceptor selectivity than 3-PPP enantiomers.

  1984cites this paper
• Stimulation of presynaptic dopamine autoreceptors by 4-(2-di-n-propylaminoethyl) indole (DPAI).

  1984cites this paper
• Interaction of (+)- and (-)-3-PPP with the dopamine receptor in the anterior pituitary gland.

  1984cites this paper
• The metabolism of dopamine, NN‐dialkylated dopamines and derivatives of the dopamine agonist 2−amino‐dihydroxy−1,2,3,4−tetrahydronaphthalene (ADTN) by catechol‐O‐methyltransferase

  1984cites this paper
• Mouse locomotor activity: an in vivo test for dopamine autoreceptor activation.

  1984cites this paper
• Inhibition of dihydropteridine reductase by novel 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs.

  1984cites this paper
• Action of putative dopamine receptor agonists, TL-99, 3-PPP and RDS-127 on substantia nigra neurons.

  1984cites this paper
• Synthesis and dopaminergic activity of 3-(3,4-dihydroxyphenyl)-1-n-propylpyrrolidine hydrobromide.

  1984cites this paper
• Interaction of the component enantiomers of the putative dopamine autoreceptor agonist, TL-99 (6,7-dihydroxy-2-dimethylamino tetralin) with dopaminergic systems in mammalian brain and teleost retina

  1983cites this paper
• Assessment of the chloroethyl analog of 3-PPP (N-n-propyl-3-(3-hydroxyphenyl)-piperidine), 3-PPP-C1 as an irreversible ligand for central dopaminergic recognition sites.

  1983cites this paper
• Characterization of dopamine autoreceptor and [3H]spiperone binding sites in vitro with classical and novel dopamine receptor agonists.

  1983cites this paper
• Different actions of TL-99 and 3-PPP in producing contraversive turning in the 6-OHDA-lesioned rat.

  1983cites this paper
• Differential effects of the enantiomers of 3-(3-hydroxyphenyl)-N-n-propylpiperidine (3-PPP) at dopamine receptor sites.

  1983cites this paper
• Postsynaptic striatal dopamine agonist or antagonist actions of (+) or (-) 3-PPP and modification after receptor deafferentation.

  1983cites this paper
• Differential behavioural effects of dopamine agonists in developing rats: a study of 3-PPP enantiomers.

  1983cites this paper
• Structure-activity relationships of dopamine agonists.

  1983cites this paper
• An alternative approach to developing dopamine‐receptor agonists with central presynaptic actions following oral administration: A comparison between apomorphine, bromocriptine, and the novel compound RDS‐127 (2‐di‐n‐propylamino‐4,7‐dimethoxyindane)

  1983cites this paper
• Avoidance and ICSS behavioral models dissociate TL-99 and 3-PPP from dopamine receptor antagonists.

  1983cites this paper
• Postsynaptic dopamine agonist properties of TL-99 are revealed by yohimbine co-treatment.

  1983cites this paper
• Effect of two dopamine agonists, TL-99 and 3-PPP, on prolactin secretion in the rat.

  1983cites this paper
• RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist.

  1983cites this paper
• Dopamine receptors involved in prolactin secretion pharmacologically characterized by means of 3-PPP enantiomers.

  1983cites this paper
• 6,7-Dihydroxy-2-dimethylaminotetralin (TL-99) stimulates postjunctional D-1 and D-2 dopamine receptors.

  1983cites this paper
• trans-N-n-Propyl-7-hydroxy-octahydrobenzo(f)quinoline, a rigid 3-PPP analogue with greater potency but lack of selectivity for dopamine autoreceptors.

  1983cites this paper
• Similarities of the effects of apomorphine and 3-PPP on serotonin neurons.

  1983cites this paper
• Is TL-99 a selective presynaptic dopamine receptor agonist?

  1982cites this paper
• Interaction of the putative dopamine autoreceptor agonists, 3-PPP and TL-99, with the dopamine-sensitive adenylate cyclase of carp retina.

  1982cites this paper
• Proceedings of the joint meeting of the Scandinavian and British Pharmacological Societies. Stockholm--Sweden. 5th and 6th July, 1982.

  1982cites this paper
• Effects of putative dopamine autoreceptor agonists in pharmacological models related to dopaminergic and neuroleptic activity.

  1982cites this paper
• Potent dopamine agonist activity of a novel ergoline, 6-ethyl-9-oxaergoline (EOE).

  1982cites this paper
• Dopamine agonists stimulate protein carboxylmethylation in striatal synaptosomes.

  1982cites this paper
• A pharmacological comparison of 6,7-dihydroxy-2-dimethylaminotetralin (TL-99) and N-n-propyl-3-(3-hydroxyphenyl)piperidine with (3-PPP) selected dopamine agonists.

  1982cites this paper
• Dopamine receptors and 3-PPP, a P-ossible P-referential P-resynaptic agonist?

  1982cites this paper
• Interaction of the putative dopamine autoreceptor agonists 3-PPP and TL-99 with [3H]apomorphine binding sites in rat striatal membranes.

  1982cites this paper
• Structure activity relationships of presynaptic dopamine receptor agonists.

  1982cites this paper
• Dopamine autoreceptor stimulation: clinical significance.

  1982cites this paper